AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
AZN Key Statistics
AZN News
London, UK --News Direct-- ANGLE PLC ANGLE PLC chief executive Andrew Newland joins Proactive's Stephen Gunnion with news the company has entered a significant...
Morsa Images/DigitalVision via Getty Images Over the last twelve months, investors applauded as the S&P 500 climbed over 21%. Unfortunately, investors in Astr...
United Kingdom-based liquid biopsy company Angle (OTCQX:ANPCY) has signed a supplier agreement with the biopharmaceutical company AstraZeneca (NASDAQ:AZN) to ta...
Analyst ratings
73%
of 30 ratingsMore AZN News
ANGLE plc (GB:AGL) has released an update. ANGLE plc has announced a new agreement with AstraZeneca to customize ANGLE’s DNA damage response assay for use in p...
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those...
AstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last reported quarter, the company missed earnings expectations by...
Voydeya has been approved in the European Union as an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal haemoglo...
Key Insights Given the large stake in the stock by institutions, AstraZeneca's stock price might be vulnerable to their trading decisions The top 18 sharehold...
In its upcoming report, Astrazeneca (AZN) is predicted by Wall Street analysts to post quarterly earnings of $0.95 per share, reflecting a decline of 1% compare...
Loading... Loading... Financial giants have made a conspicuous bearish move on AstraZeneca. Our analysis of options history for AstraZeneca AZN revealed 12 unu...
